Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | CES2 | O00748 | 2/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 2/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.37 |
| ▸ | MGLL | Q99685 | 1/20 | 0.37 |
| ▸ | TMPRSS4 | Q9NRS4 | 5/20 | 0.37 |
| ▸ | NQO2 | P16083 | 1/20 | 0.37 |
| ▸ | PDE2A | O00408 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.36 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.36 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25400369 | 1.00 | GAA (0.46) | GAAMEN1KMT2ACES2PTGS2 | |
| SCHEMBL24440730 | 0.83 | CES2 (0.39) | GAAMEN1KMT2ACES2PDE2A | |
| SCHEMBL17141748 | 0.79 | MEN1 (0.43) | GAAMEN1KMT2ACES2PTGS2 | |
| SCHEMBL320481 | 0.75 | CES2 (0.52) | MEN1KMT2ACES2TMPRSS4ALDH1A1 | |
| SCHEMBL30062195 | 0.75 | CES2 (0.52) | MEN1KMT2ACES2TMPRSS4ALDH1A1 | |
| SCHEMBL686342 | 0.72 | KDM1A (0.57) | GAAMEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL24450665 | 0.71 | MEN1 (0.47) | MEN1KMT2ACES2TMPRSS4ALDH1A1 | |
| SCHEMBL18817944 | 0.71 | TMPRSS4 (0.46) | GAAMEN1KMT2ACES2PTGS2 | |
| SCHEMBL18817947 | 0.71 | TMPRSS4 (0.46) | GAAMEN1KMT2ACES2PTGS2 | |
| SCHEMBL9921091 | 0.70 | KDM1A (0.69) | GAAMEN1KMT2AALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4244910-B1 | CERIUM-ETHYLENEDIAMINE KETONE-TYPE AND CERIUM-SALEN-TYPE COMPLEXES AND USE THEREOF IN ORGANIC ELECTRONICS | Credoxys GmbH (DE) | 2024-12-11 | — | — | EP | disclosed |
| US-20230422602-A1 | CERIUM-ETHYLENEDIAMINE KETONE-TYPE AND CERIUM-SALEN-TYPE COMPLEXES AND USE THEREOF IN ORGANIC ELECTRONICS | Credoxys GmbH (DE) | 2023-12-28 | — | — | US | disclosed |
| EP-4244910-A1 | CERIUM-ETHYLENEDIAMINE KETONE-TYPE AND CERIUM-SALEN-TYPE COMPLEXES AND USE THEREOF IN ORGANIC ELECTRONICS | Credoxys GmbH c/o Institut for Applied Physics (DE) | 2023-09-20 | — | — | EP | disclosed |
| WO-2022101343-A1 | CERIUM-ETHYLENEDIAMINE KETONE-TYPE AND CERIUM-SALEN-TYPE COMPLEXES AND USE THEREOF IN ORGANIC ELECTRONICS | Credoxys GmbH (DE) | 2022-05-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230422602-A1 | CERIUM-ETHYLENEDIAMINE KETONE-TYPE AND CERIUM-SALEN-TYPE COMPLEXES AND USE THEREOF IN ORGANIC ELECTRONICS | KCNH3, KCNE1, PDHA1 | GAA 976/4885MEN1 2588/4885KMT2A 1571/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.